High cost inflation and rising interest rates have impacted consumer confidence and weakened consumers’ expectations of their own economy. In the fourth quarter, volumes in the pharmaceutical distribution market in Sweden grew while volumes in Finland declined. Market value continued steady growth in both countries. The solid underlying long-term market drivers such as ageing population, wellbeing and health remain unchanged.
The challenges in the availability of some pharmaceuticals have remained tight across Europe. Energy and fuel prices have stabilised.
As published in the Financial Statements Release 2023 on 16 February 2024.